Physician profile
Erik Haniuk
NPI 1255786240
$4,771.76
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,610 · 2020: $41.16 · 2021: $247 · 2022: $425 · 2023: $347 · 2024: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $2,985.33 | 2019 | |
| Orthofix Medical, INC. | $552.22 | 2019-2024 | Physio-Stim |
| Stryker Corporation | $476.81 | 2019-2022 | |
| Integra Lifesciences Corporation | $267.67 | 2019-2020 | |
| Flower Orthopedics Coporation | $155.86 | 2021-2022 | |
| Inari Medical, INC. | $105.90 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organogenesis INC. | $86.04 | 2019 | |
| Smith+Nephew, INC. | $59.76 | 2021-2023 | Grafix Pl |
| Bioventus LLC | $28.43 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $26.24 | 2022-2023 | Dynasplint |
| Paratek Pharmaceuticals, INC. | $15.43 | 2023 | Nuzyra |
| Kci USA, INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Haniuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.